Celltrion Pharm Market Cap

Celltrion Pharm has a market cap or net worth of 3.12 trillion as of February 27, 2026. Its market cap has increased by 41.33% in one year.

Market Cap

3.12T

Enterprise Value

n/a

Revenue

274.73B

Ranking

n/a

PE Ratio

123.08

Stock Price

71,800.00

Market Cap Chart

Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 3.12T, an increase of 4,605.35%. That is a compound annual growth rate of 21.14%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	3,123.01B	21.36%
Dec 30, 2025	2,573.33B	4.33%
Dec 30, 2024	2,466.43B	-35.41%
Dec 28, 2023	3,818.49B	44.48%
Dec 29, 2022	2,642.93B	-43.45%
Dec 30, 2021	4,673.68B	-46.31%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hanall Biopharma	3,102.65B
Daewoong Pharmaceutical	2,082.63B
GC Biopharma	1,900.29B
Hanmi Pharm.	7,532.05B
Chong Kun Dang Pharmaceutical	1,222.74B
Yuhan	8,237.39B
Ildong Pharmaceutical	1,164.22B
Daewoong	1,122.45B

Market Cap Rankings